Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Stopped Study terminated due to low subject enrollment. Safety results consistent with product label.

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG: adalimumab (up to 9 months exposure)
• DRUG: methotrexate

Sponsor

Abbott